Who owns the ZIMPHIQUE trademark?

The ZIMPHIQUE trademark is owned by Alexion Pharma International Operations Limited.

What class is the ZIMPHIQUE trademark registered in?

The ZIMPHIQUE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for ZIMPHIQUE?

The USPTO serial number for ZIMPHIQUE is 98777907.

What is the registration number for ZIMPHIQUE?

ZIMPHIQUE is registered under USPTO registration number 8300179.

ZIM

USPTO Trademark Record

REGISTERED

ZIMPHIQUE

SN 98777907·Reg 8300179·Filed Sep 30, 2024

Owner Alexion Pharma International Operations Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ZIMPHIQUE (Serial No. 98777907), Registration No. 8300179, is a registered US trademark filed on Sep 30, 2024 by Alexion Pharma International Operations Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: June 16, 2032

Mark Intelligence

ZIMPHIQUE (Reg. #8300179) is a registered US trademark that has been protecting its owner, Alexion Pharma International Operations Limited, since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 30, 2024

SERIAL

98777907

REG#

8300179

REGISTERED

Jun 16, 2026

Owner

Applicant

Alexion Pharma International Operations Limited

Entity

Not Provided

Address

Blanchardstown Road North, Dublin 15, Dublin, D15R925

Country

Attorney

NameCara M. Kearney

Law firm

Cara M. Kearney AstraZeneca Pharmaceuticals LP

Docket

104687/US

Address

1800 Concord Pike, A2C, Wilmington, DE 19850-5437, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 30, 2024

Serial Number98777907

Registration No.8300179

Registration DateJun 16, 2026

Status DateJun 16, 2026

Published for OppositionNov 04, 2025

Mark TypeStandard characters

Attorney Docket104687/US

Status DescriptionLive and registered

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

21 events

REGISTERED-PRINCIPAL REGISTER

Jun 16, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 16, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

1(B) BASIS DELETED; PROCEED TO REGISTRATION

May 22, 2026

1(B) BASIS DELETED; PROCEED TO REGISTRATION

TEAS DELETE 1(B) BASIS RECEIVED

May 01, 2026

TEAS DELETE 1(B) BASIS RECEIVED

NOTICE OF ALLOWANCE CANCELLED

May 01, 2026

NOTICE OF ALLOWANCE CANCELLED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 30, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Nov 04, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 04, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 29, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 01, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 23, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 22, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 22, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jun 17, 2025

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jun 17, 2025

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

NON-FINAL ACTION WRITTEN

Mar 24, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 24, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 24, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 19, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Sep 30, 2024

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 30, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

ZIMPHIQUE

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Alexion Pharma International Operations Limited

Other Marks by Cara M. Kearney

Resources

Company